These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1994382
1. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein. Björk P, Jönsson U, Andrén-Sandberg A. Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382 [Abstract] [Full Text] [Related]
2. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol. Forsgren B, Gustafsson JA, Pousette A, Högberg B. Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694 [Abstract] [Full Text] [Related]
4. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes. Forsgren B, Björk P, Carlström K, Gustafsson JA, Pousette A, Högberg B. Prog Clin Biol Res; 1981 Dec; 75A():391-407. PubMed ID: 7339627 [Abstract] [Full Text] [Related]
5. Accumulation of estramustine and estromustine in adipose tissue of rats and humans. Gunnarsson PO, Andersson SB, Sandberg AA, Ellman M. Cancer Chemother Pharmacol; 1991 Dec; 28(5):361-4. PubMed ID: 1914079 [Abstract] [Full Text] [Related]
6. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity]. Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E. Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830 [Abstract] [Full Text] [Related]
9. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis. Daehlin L, Södergård R, Damber JE. Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367 [Abstract] [Full Text] [Related]
10. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans. Bergenheim AT, Gunnarsson PO, Edman K, von Schoultz E, Hariz MI, Henriksson R. Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366 [Abstract] [Full Text] [Related]
11. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression. Björk P, Isaacs JT, Hartley-Asp B. Prostate; 1991 Feb; 18(3):181-200. PubMed ID: 2020618 [Abstract] [Full Text] [Related]
13. Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma. Björk P, Borg A, Fernö M, Nilsson S. Anticancer Res; 1991 Feb; 11(3):1173-82. PubMed ID: 1888147 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients. Gunnarsson PO, Andersson SB, Johansson SA, Nilsson T, Plym-Forshell G. Eur J Clin Pharmacol; 1984 Feb; 26(1):113-9. PubMed ID: 6714283 [Abstract] [Full Text] [Related]
16. Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues. Hoisaeter PA. Acta Endocrinol (Copenh); 1976 Jul; 82(3):661-72. PubMed ID: 947135 [Abstract] [Full Text] [Related]
17. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma. Andersson SB, Gunnarsson PO, Nilsson T, Forshell GP. Eur J Drug Metab Pharmacokinet; 1981 Jul; 6(2):149-54. PubMed ID: 7274309 [Abstract] [Full Text] [Related]
19. Purification of estramustine-binding protein and production of monoclonal antibodies to its different components. Björk P, Donn F, Glad C, Sundblad G, Vestberg M, Kalland T. Prostate; 1995 Aug; 27(2):70-83. PubMed ID: 7638085 [Abstract] [Full Text] [Related]
20. Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan. Yamanaka H, Imai K, Yuasa H, Shida K. Prostate; 1981 Aug; Suppl 1():95-102. PubMed ID: 7043423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]